1932

Abstract

The peroxisome biogenesis disorders (PBDs) comprise 12 autosomal recessive complementation groups (CGs). The multisystem clinical phenotype varies widely in severity and results from disturbances in both development and metabolic homeostasis. Progress over the last several years has lead to identification of the genes responsible for all of these disorders and to a much improved understanding of the biogenesis and function of the peroxisome. Increasing availability of mouse models for these disorders offers hope for a better understanding of their pathophysiology and for development of therapies that might especially benefit patients at the milder end of the clinical phenotype.

Loading

Article metrics loading...

/content/journals/10.1146/annurev.genom.4.070802.110424
2003-09-01
2024-03-29
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.genom.4.070802.110424
Loading
/content/journals/10.1146/annurev.genom.4.070802.110424
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error